Effects of Therapy With [177Lu-DOTA0,Tyr3]octreotate on Endocrine Function

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-009-1151-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors With [177Lu-DOTA0,Tyr3]Octreotate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

[177Lu]-Dota0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2010English

P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2016English

Rapid Kit-Based 68Ga-Labelling and PET Imaging With THP-Tyr3-octreotate: A Preliminary Comparison With DOTA-Tyr3-octreotate

EJNMMI Research
Nuclear MedicineRadiologyImaging
2015English

Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

Adverse Effects of Adjuvant Endocrine Therapy

Medical Council
2018English

Potential Biomarkers for Radiation-Induced Renal Toxicity Following 177Lu-Octreotate Administration in Mice

PLoS ONE
Multidisciplinary
2015English

Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy